A 20-patient study showed its ultrasound PAD balloon was effective in patients with arterial blockage below the knee.

Days after the FDA approved Optinose’s nasal polyp drug, its commercialization will be the focus of a post-IPO spending spree.

The FDA cleared Medtronic's latest spinal cord stimulation system for the treatment of chronic intractable pain.

Mologic received a CE mark for its point-of-care test that rapidly diagnoses bacterial vaginosis.

Rob Brainin jumped ship from Illumina and has been named executive vice president and chief operating officer of the genomics company WuXi NextCODE.

NuVasive's LessRay system for reducing exposure to radiation in hospital operating rooms—and particularly keyhole spinal surgery—has been given the go-…

LivaNova decided to look to offload the $250 million-a-year pacemaker and defibrillator unit after concluding it no longer fits with its strategy.

The Pear Therapeutics app delivers cognitive behavioral therapy to help patients abstain from substance abuse and stay in outpatient programs.